9.090USD-5.51%Mkt Cap: 1.53B USDP/E: —Last update: 2026-06-01
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical dev…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.53B USD
Enterprise Value1.23B USD
Revenue (TTM)65.50M USD
Gross Profit66.49M USD
Net Income (TTM)-437.99M USD
Revenue/Share0.4650 USD
Last Price9.090 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees367
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.15
PEG—
EV/EBITDA-2.72
EV/Revenue18.74
P/S24.57
P/B1.74
EPS (TTM)-3.13
EPS (Forward)-2.30
52W Range
4.15566% of range11.66
52W High11.66 USD
52W Low4.155 USD
Profitability
Gross Margin99.96%
Oper. Margin459241.36%
EBITDA Margin0.00%
Profit Margin-658.43%
ROE-57.23%
ROA-43.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-391.78M USD
CapEx (TTM)4.83M USD
FCF Margin-328.16%
FCF Yield-14.04%
Net Debt-380.72M USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity0.13
Current Ratio7.11
Quick Ratio6.52
Book Value/Sh5.487 USD
Cash/Share2.824 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)20.56 USD
Target Range16.00 USD – 30.00 USD
# Analysts9
Ownership
Shares Out.168.65M
Float128.81M
Insiders6.57%
Institutions81.40%
Short Interest
Short Ratio10.2d
Short % Float10.11%
Short % Out.9.98%
Shares Short16.83M
Short (prev mo.)16.81M
Technical
SMA 509.540 (-4.7%)
SMA 2007.167 (+26.8%)
Beta1.70
S&P 52W Chg27.70%
Avg Vol (30d)1.52M
Avg Vol (10d)1.72M
Technical Indicators
RSI (14)53.4
MACD-0.1110
MACD Signal-0.1636
MACD Hist.+0.0527
BB Upper10.30 USD
BB Middle9.346 USD
BB Lower8.387 USD
BB Width20.53%
ATR (14)0.4673 USD
Vol Ratio (20d)1.30x